Member Info for RayPointer

It might be just the opposite.

They might think -
Scancell are now going to trial SCIB1 in the US
That lets us off the hook in possible funding of Keytruda

On the other hand
They might think -
We want to be part of this!

Who knows?

Here's Lindy, Cliff and Chippers trying for that pivotal year

https://www.youtube.com/watch?v=QcnogXICTeA

I'm guessing that the lifestyle company attitude hadn't kicked in by 2013, so Lindy and Richard has to sell 1.3% of their joint holdings to pay for the next Christmas party.

I wonder how unique Avidimab is.
I imagine that Mabs attach themselves to a tumour and then join with each other via the mutual attraction of the Fc region (tail of Mab). I imagine this forms a blanket over the tumour that is harder to dislodge than a conventional attachment.
Then the V part of the Mab can get to work but in addition whatever is attached to the Fc region can also get to work.
As Lindy says, this is potentially a combination therapy in its own right and with the higher than normal avidity

I wonder if he has told his wife.

Just catching up
Thanks for posting this link cc

https://www.immuno-oncologyeurope.com/preclinical-immuno-oncology

I notice Lindy has top billing on day 2 of the event.

after he heard he was to receive the Noble Prize.

The actual news conference starts about 3 minute in to the youtube.

https://www.youtube.com/watch?v=ScuTG1bzSHY&list=PLMV4iprAcgNCXdl7ogDqAMJ7UsUIVhKar&index=2

You get the impression that it might be the tip of the iceberg.
There may be many other roles that elements of the immune system perform, as yet undiscovered.

I like the picture that starts the article, but surely, a bricklayer with a 3rd arm would be holding a mug of tea.

So at the moment support in the high 6s and resistance and a stubborn resistance about 8 .
A narrow range not too encouraging for traders.

Perhaps the new venue has a back door

https://www.ncbi.nlm.nih.gov/pubmed/?term=Durrant+LG

This gives a list of 137 publications by Lindy showing the latest first.
The very first publication is back in 1981.

https://brightside.me/inspiration-relationships/scientists-claim-that-couples-who-fight-a-lot-really-love-each-other-658710/

What a great interview. What a character!
Recommended reading for a wet and windy Sunday.

Sorry, I misread this.
The researchers are trying to encourage autophagy in this case.
Autophagy limits the virus's ability to replicate.

https://www.drugtargetreview.com/news/55567/autophagy-the-key-to-effective-mers-coronavirus-treatment/

Another indication of the importance of Autophagy, in this case the researchers are trying to inhibit it.

"The researchers also observed a previously unknown molecular switch that regulates the process of autophagic degradation: the SKP2 protein. They discovered that the MERS virus activates this molecular switch in order to slow down the cell’s recycling processes and avoid degradation. Using these insights, the researchers treated MERS-infected cells with various SKP2 inhibitors in order to stimulate the degradation process and this strategy proved successful."

Yes, the 10 million or whatever is the development cost of new products.
The cost of sales of existing products is zero for Scancell.
The licensee bears the cost of sales.

Surely, there is no cost of sales.

But the accountant would still have to light his office and pay for a cleaner.

Be interesting to see if the SP settles around this level or continues down to 6p.
Support and resistance getting closer together?

I should have stated Modi1 TCR.